Zonisamide for Epilepsy May Ease Parkinson’s Motor Symptoms: Study
Zonisamide, an epilepsy medication approved in the U.S. for some seizure-causing disorders, may reduce the motor symptoms of Parkinson’s…
Articles by Marisa Wexler, MS
CBD Found to Improve Survival in Worm Models of Parkinson’s
Treatment with cannabidiol (CBD) prevented nerve cell death, extended survival, and reduced toxic protein clumps in nematode worm models of…
AI-based Tool May Help Minimize Side Effects of Anticholinergic Medicines
A new online tool based on artificial intelligence could help reduce possible side effects from anticholinergic medications, a class of…
Probiotic Supplements Found to Ease Parkinson’s Constipation in Trial
Probiotic supplements were found to ease multiple measures of constipation in people with Parkinson’s disease in a small clinical…
Antipsychotics Use Climbs in Years Before Parkinson’s Diagnosis: Study
The use of antipsychotic medications is substantially more common among people with Parkinson’s disease than in the general population,…
Dopamine Agonists Linked to Poorer Blood Vessel Function
Rates of blood vessel dysfunction are not significantly different in people with Parkinson’s disease compared to the general population,…
Alpha-synuclein Clumping Seen to Affect Mitochondria Early
Alpha-synuclein aggregation — the toxic clumping of proteins in nerve cells that is a hallmark of Parkinson’s disease —…
Dosing Begins in Phase 2 Study of Experimental Treatment IkT-148009
The first participant has been dosed in a Phase 2 clinical trial testing IkT-148009, an experimental oral therapy for…
Swallow Tail Sign, Parkinson’s MRI Marker, in Distinct Brain Region
A feature on MRI images called the “swallow tail sign” has long been thought to correspond to a dopaminergic brain…
GPNMB Protein May Be Parkinson’s Biomarker, Treatment Target: Study
Levels of a protein called glycoprotein nonmetastatic melanoma protein B (GPNMB) are elevated in the blood of people with…